Skip to main content

Table 4 Target population and intercurrent event handling by outcome variable groupings

From: Statistical analysis plan for the Prenatal Iodine Supplementation and Early Childhood Neurodevelopment (PoppiE) randomised controlled trial

Outcomes

Estimand attributes

1–17: Infant cognitive development and anthropometrics at 24 months of age

Target population: Infants of mothers with adequate iodine intake from food early in pregnancy (> 165 µg/day) who survive to 24 months of age

Intercurrent events: Non-compliance with the randomised supplement regime will be ignored under a treatment policy strategy. Miscarriages, terminations, stillbirths and infant deaths will be excluded from analysis according to the target population attribute

18–24: Infant birth and birth hospitalisation characteristics

Target population: Infants of mothers with adequate iodine intake from food early in pregnancy (> 165 µg/day) who are live-born

Intercurrent events: Non-compliance with the randomised supplement regime will be ignored under a treatment policy strategy. Miscarriages, terminations and stillbirths will be excluded from analysis according to the target population attribute

25–28: Maternal complications during pregnancy, delivery type and postpartum haemorrhage

Target population: Mothers with adequate iodine intake from food early in pregnancy (> 165 µg/day) who deliver a live-born infant

Intercurrent events: Non-compliance with the randomised supplement regime will be ignored under a treatment policy strategy. Miscarriages, terminations and stillbirths will be excluded from analysis according to the target population attribute